We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test Identifies Individuals at Risk for Kidney Disease

By LabMedica International staff writers
Posted on 27 Dec 2010
Print article
An infrequently employed blood test can effectively identify individuals at increased risk of developing complications associated with chronic kidney disease (CKD).

The measurement of cystatin C levels in the blood has emerged as an alternative test of kidney function, because the protein is removed from the bloodstream by filtration in the kidneys.

Cystatin C levels rise in the blood when kidney function declines, while creatinine tests are inaccurate at detecting mild kidney impairment, and creatinine levels can vary with muscle mass and protein intake. In a study carried out at the San Francisco Veterans Affairs Medical Center, (San Francisco, CA, USA), 11,909 participants were investigated for various aspects of cardiovascular disease. The investigators defined CKD using both creatinine and cystatin C and compared their links to higher risks for premature death, cardiovascular events, heart failure, and kidney failure-all of which are known complications of CKD. Cystatin C was measured by means of a particle enhanced immunonephelometric assay (N Latex Cystatin C) with a nephelometer, both from Siemens Healthcare Diagnostics, (Deerfield, IL, USA).

In the group from a study of atherosclerosis (MESA), 9% of individuals had CKD by a creatinine-based equation only, 2% had CKD by a cystatin C-based equation only, and 4% had CKD by both equations. In the group from a cardiovascular health study (CHS), these percentages were 12%, 4%, and 13%, respectively. Compared with those without CKD, individuals in MESA with CKD based on creatinine only had similar risk of premature death, while individuals with CKD based on cystatin C only had more than a 3-fold increased risk, and those with CKD based on both had nearly a 2-fold increased risk.

The authors concluded that among adults diagnosed with CKD using the creatinine-based equation, poor prognosis is limited to patients who also have CKD according to the cystatin C-based equation. Therefore, cystatin C may have an important role in distinguishing the persons suspected of having CKD, based on the current creatinine definition, who have the highest risk for CKD complications. In addition, cystatin C may identify persons with high risk for CKD complications who are currently missed by creatinine. The study was published on December 16, 2010, in Journal of the American Society Nephrology.

Related Links:

San Francisco VA Medical Center
Siemens Healthcare Diagnostics




Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Aspergillus Test
REALQUALITY Aspergillus

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.